A study to find out more about biomarkers in kidney cancer

Cancer type:

Kidney cancer
Renal cell cancer

Status:

Results

Phase:

Other

In this study doctors wanted to develop tests for biomarkers that could help in the assessment and treatment of kidney cancer.

The study was open for people to join between 2011 and 2014. The team reported the results in 2018. There is a link to more information in the ‘Summary of results’ section below.

More about this trial

A biomarker is a substance in the body that doctors can measure. They are often proteins. They can help tell doctors how likely it is that a cancer is growing, or how well treatment is working.

In this study, doctors looked at blood and urine samples from:

  • people with kidney cancer 
  • people with other medical conditions
  • people without cancer or other conditions (healthy volunteers)

They looked for differences in biomarkers between the groups. The aim was to find biomarkers that could lead to a test to help diagnose or treat kidney cancer in the future.

Summary of results

We aim to add a lay summary of results to all the studies on our database. Unfortunately we have not been able to include a summary for this one.

There is more information about the results in the link below.

Methods for the evaluation of biomarkers in patients with kidney and liver diseases: multicentre research programme including ELUCIDATE RCT
Peter J Selby and others
NIHR Journals Library, June 2018. Programme Grants for Applied Research, No. 6.3.

Please note, the document we link to here is not in plain English. It has been written for healthcare professionals and researchers. But it does include a short plain English summary written by the research team.

Recruitment start:

Recruitment end:

How to join a clinical trial

Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Chief Investigator

Professor Rosamonde Banks

Supported by

Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
University of Leeds

If you have questions about the trial please contact our cancer information nurses

Freephone 0808 800 4040

Last review date

CRUK internal database number:

Oracle 8974

Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.

Charlie took part in a trial to try new treatments

A picture of Charlie

“I think it’s really important that people keep signing up to these type of trials to push research forward.”

Last reviewed:

Rate this page:

No votes yet
Thank you!
We've recently made some changes to the site, tell us what you think